After more than two decades of paternity testing, Genelex has sold its paternity testing division to DNA Diagnostics Center, allowing the company to respond to multiple years of 200%+ growth in pharmacogenetic testing and redouble its focus on the YouScript® Personalized Prescribing System.

Genelex was founded in 1987 and since then has been relied upon by state and international agencies for forensic and relationship testing to help solve complex cases and process immigration applications.

In 2000, Genelex became one of the first labs to provide pharmacogenetic (also known as pharmacogenomic) testing, and today the company’s high-capacity laboratory offers 9 pharmacogenetic tests and processes thousands of samples every month.

The company’s high accuracy results, clinical decision support tools and pharmacist support make it a recognized leader in pharmacogenetic testing and personalized medication management software.